Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
merron schreef op 25 februari 2019 18:46 :
cijfers zijn zo slecht , ze durven niet, lol!
Nabeurs, zal gewoon na sluiting US worden, na morgen strak richting de € 30,- binnen enkele weken, hihihihi !!!
Dit duurt te lang! Ik ga op bed. Tot morgen iedereen. Opening op € 26 ?
stockholder schreef op 25 februari 2019 18:48 :
Dit duurt te lang! Ik ga op bed. Tot morgen iedereen. Opening op € 26 ?
Minstens, ik kijk na 22.00 uur of ik de komende maanden/jaar goed zit, hahaha !!!
Mijn verwachting is en was vandaag rond de klok van 22.15 uur, tot straks !!!
Dicall69 schreef op 15 februari 2019 10:59 :
Hopelijk zien we maandag 25 februari, nabeurs dat OCI de volgende jaarcijfers bij benadering heeft behaald :
Omzet van rond de 3,1 miljard en liefst hoger Ebitda van 920 miljoen of hoger Een positieve nettowinst over heel 2018, hoe klein dan ook Cashflow verwacht ik inmiddels boven de 300 miljoen Schuldratio tussen de 3 en 4 Bovenstaand zou betekenen dat men in het vierde kwartaal als volgt heeft gepresteerd :
Omzet ongeveer 770 miljoen Ebitda ongeveer 240 miljoen Nettowinst van minimaal 30 miljoen Cashflow ongeveer 75 miljoen Schuldenratio gedaald van 5,5 beneden 4 Ben benieuwd, hoe andere forumleden de resultaten over 2018 inschatten, daarbij verwacht ik dat de vooruitzichten/ outlook over 2019 heel goed zullen zijn !!!
Ben benieuwd,hoe mijn prognose overeind blijft ten opzichte van wat OCI daadwerklijk heeft gepresteerd ???
Wel, dat kon wel eens heel verrassend zijn. Je zou denken er is voorbeurs wel wat voorkennis en de koers vandaag nog een zet geven... Hopelijk gaat dat morgen gebeuren...
HIER ZIJN DE CIJFERS !!!!!! OCI N.V. REPORTS 2018 RESULTS =========================== February 25 2019 OCI N.V. Q4 2018 Results Report Final vF.pdf OCI N.V. Reports Strong Free Cash Flow in Q4 2018 Highlights: Strong free cash flow generation of $305 million and a reduction in net debt of $295 million during the fourth quarter of 2018 Own-produced volumes sold increased 20% during Q4 2018 compared to Q4 2017 resulting in a record 9.4 million metric tons for the full year 2018 Revenues increased 47% during Q4 2018 versus Q4 2017 driven by higher volumes and higher selling prices Adjusted EBITDA increased 102% to $269 million in Q4 2018 from $133 million in Q4 2017 driven by the higher revenues and higher margins Adjusted net income improved to $17 million in Q4 2018 from a loss of $53 million in Q4 2017 The improvement in leverage metrics continued with a trailing net debt / adjusted EBITDA of 4.4x at 31 December 2018, down from 7.0x at 31 December 2017 and 5.5x at 30 September 2018 Statement from the Chief Executive Officer – Nassef Sawiris: “We ended 2018 with a robust quarter. We more than doubled our Adjusted EBITDA compared to the same quarter a year ago and generated strong free cash flow which delivered a significant reduction of $295 million in net debt during the fourth quarter and excellent progress on our deleveraging priority. This growth demonstrates that our previous investments in new capacities are starting to pay off with a solid performance at Iowa Fertilizer Company and the ramp-up and first cash dividend from Natgasoline. We achieved this volume and earnings growth despite a shutdown at Natgasoline during the fourth quarter due to utilities supply issues that have now been resolved, coupled with low water levels in the Rhine which affected despatches of CAN in Europe. As a company we view selling forward large quantities of product to wholesalers during the low season at low prices as value destructive, as it creates an unnecessary overhang in the market when distributors become competitors during the peak season. We believe that our approach, combined with our strategic locations, and the strong execution of our operational teams has allowed us to capture the benefits of a rising pricing environment during the third and fourth quarters of 2018, maximize netback prices and outperform the industry in North America. Our positioning in the Upper Midwest of the United States is unique and gives us significant freight and logistical advantages. This becomes even more prominent in the spring season, when the availability of river barges and other logistical challenges (such as congestion on the rivers and railroads) become a bottleneck for product that is to be transported into the Midwest originating from New Orleans (NOLA). We expect our low-cost operations in the United States to be a key source of growth in 2019. Towards the end of 2018, IFCo reached record production levels of 115% of nameplate capacity as a result of both optimization work and an increase in our permitted production levels as described last quarter. This has resulted in a significant improvement in EBITDA performance at IFCo during the fourth quarter. We expect continued improvement at IFCo in 2019 due to several factors, including consistent production performance, the full effect of the increase in allowable operating rates, and a significant increase in diesel exhaust fluid volumes. We also expect our methanol business to grow in 2019 to reach 2.95 million metric tons of proportionate production capacity. Natgasoline will have its first full year of operations, BioMCN’s second line is due to start up this spring and we expect to finalize the c.13% methanol capacity increase at OCI Beaumont this summer.” Outlook Focus on Nitrogen Products Our diversified portfolio of nitrogen products consists of fertilizer, diesel exhaust fluid and melamine: Short term, we expect a portion of our sold fertilizer volumes to shift from the first into the second quarter as demand starts picking up in March / April. Our disciplined sales approach will result in some inventory build-up towards the end of the quarter. Nitrogen prices have declined at the beginning of 2019 as a result of the impact of a delayed application season and continued exports from Iran, but we expect global demand to materialize through 2019 as seasonal demand kicks in. The outlook is especially strong in the US for the second quarter of 2019: in Q4 2018, ammonia application rates were at historically low levels due to inclement weather, which we expect to result in a boost in demand in spring. In addition, the US Department of Agriculture (USDA) recently estimated that an additional 3 million acres of corn will be planted in the US this season which is supportive of nitrogen demand. We continue to expect a tightening of the global supply and demand balance with new capacity additions below historical trend demand growth of c.2% per annum and exports from China at low levels. Melamine remains a cornerstone of our Dutch operations, enjoying another good performance in 2018 with contract prices on average 8% higher than the year before and a stable performance in the past few quarters. We expect to continue to capture healthy margins for this business. The outlook for the diesel exhaust fluid market in the US remains positive and is expected to grow at rates over 15% per annum in the coming years. As a result of the recent DEF plant expansion, investment in related infrastructure, and the establishment of the N-7 joint venture, we have already concluded several 2019 contracts totalling more than double the DEF sales volumes achieved in 2018.
Focus on Methanol Fundamentals of methanol markets are unchanged: For methanol we also expect limited new major capacity additions in the next 4-5 years relative to expected demand growth rates in the mid-single digits. Following some price weakness at the end of 2018 due to the decrease in oil prices and lower utilization rates at MTO facilities in China, prices have rebounded in the past weeks, and markets in Asia have picked up after Chinese New Year. Firming oil prices, increasing utilization rates of methanol-to-olefins (MTO) plants and the addition of multiple new MTO facilities in China should be supportive for methanol prices and demand. Gas Markets Our cost position is looking favourable with a low blended average natural gas cost. We have a mix of long-term contracts with fixed gas prices in Egypt and Algeria, and spot prices in Europe and the Unites States. Gas prices have moderated in both Europe and the United States since the levels reached in 2018. We expect to see the full benefit of the lower gas prices from the second quarter onwards as our European winter exposure hedges expire. In the United States, we continue to benefit from the hedges of $2.42 per mmBtu at IFCo for the majority of our gas needs in Q1 and have secured prices below $2.30 per mmBtu for Q2. Despite US sanctions, Iran has continued to export significant volumes at heavily discounted prices in recent months, negatively impacting methanol and fertilizer markets. With export volumes of more than 4 million tons each of urea and methanol in 2018, Iran is one of the largest exporters of both these products globally. However, as sanctions are now being fully implemented and export opportunities for the country diminish, Iranian exports are likely to decline in 2019. We are well-positioned to benefit from improving end markets through the unique strategic positioning of our assets in key regions, our globally competitive low-cost asset base and best-in-class free cash flow conversion. We expect continued growth in EBITDA and improvement of our leverage metrics in 2019. Net interest and capital expenditures are expected to decrease in 2019, which should contribute positively to our cash flows: Interest expense of $341 million in 2018 is expected to decrease by $50-70 million in 2019, also benefiting from a 50bps step-down with every half turn in net debt to EBITDA metrics on OCI NV’s bank facilities. Capital expenditures are expected to be c.$200-220 million, of which around $150-160 million for maintenance capital expenditure and an estimated $50-60 million for growth, including the capacity expansion at OCI Beaumont. We remain committed to our financial policy to prioritise these expected strong free cash flows towards deleveraging to 2x through the cycle.
Ongelooflijk sterke prestatie !!! OCI N.V. Reports Strong Free Cash Flow in Q4 2018 Highlights: Strong free cash flow generation of $305 million and a reduction in net debt of $295 million during the fourth quarter of 2018 Own-produced volumes sold increased 20% during Q4 2018 compared to Q4 2017 resulting in a record 9.4 million metric tons for the full year 2018 Revenues increased 47% during Q4 2018 versus Q4 2017 driven by higher volumes and higher selling prices Adjusted EBITDA increased 102% to $269 million in Q4 2018 from $133 million in Q4 2017 driven by the higher revenues and higher margins Adjusted net income improved to $17 million in Q4 2018 from a loss of $53 million in Q4 2017 The improvement in leverage metrics continued with a trailing net debt / adjusted EBITDA of 4.4x at 31 December 2018, down from 7.0x at 31 December 2017 and 5.5x at 30 September 2018www.oci.nl/investor-relations/news/20...
Focus on Methanol Fundamentals of methanol markets are unchanged: For methanol we also expect limited new major capacity additions in the next 4-5 years relative to expected demand growth rates in the mid-single digits. Following some price weakness at the end of 2018 due to the decrease in oil prices and lower utilization rates at MTO facilities in China, prices have rebounded in the past weeks, and markets in Asia have picked up after Chinese New Year. Firming oil prices, increasing utilization rates of methanol-to-olefins (MTO) plants and the addition of multiple new MTO facilities in China should be supportive for methanol prices and demand. Gas Markets Our cost position is looking favourable with a low blended average natural gas cost. We have a mix of long-term contracts with fixed gas prices in Egypt and Algeria, and spot prices in Europe and the Unites States. Gas prices have moderated in both Europe and the United States since the levels reached in 2018. We expect to see the full benefit of the lower gas prices from the second quarter onwards as our European winter exposure hedges expire. In the United States, we continue to benefit from the hedges of $2.42 per mmBtu at IFCo for the majority of our gas needs in Q1 and have secured prices below $2.30 per mmBtu for Q2. Despite US sanctions, Iran has continued to export significant volumes at heavily discounted prices in recent months, negatively impacting methanol and fertilizer markets. With export volumes of more than 4 million tons each of urea and methanol in 2018, Iran is one of the largest exporters of both these products globally. However, as sanctions are now being fully implemented and export opportunities for the country diminish, Iranian exports are likely to decline in 2019. We are well-positioned to benefit from improving end markets through the unique strategic positioning of our assets in key regions, our globally competitive low-cost asset base and best-in-class free cash flow conversion. We expect continued growth in EBITDA and improvement of our leverage metrics in 2019. Net interest and capital expenditures are expected to decrease in 2019, which should contribute positively to our cash flows: Interest expense of $341 million in 2018 is expected to decrease by $50-70 million in 2019, also benefiting from a 50bps step-down with every half turn in net debt to EBITDA metrics on OCI NV’s bank facilities. Capital expenditures are expected to be c.$200-220 million, of which around $150-160 million for maintenance capital expenditure and an estimated $50-60 million for growth, including the capacity expansion at OCI Beaumont. We remain committed to our financial policy to prioritise these expected strong free cash flows towards deleveraging to 2x through the cycle.
Hatsieflats! Daar kunnen we mee vooruit in 2019
Ik werd hier uitgelachen met mn cashflow prognoses!!! En jahoor er nog overheen zelfs! Volgend jaar gewoon minimaal 1 miljard vrije kasstroom! Morgen dikke FREEZE ...
Het wordt morgen een mooie dag......
Zeer sterke cijfers en het resultaat gaat in 2019 nog eens flink omhoog. Top aandeel voor je portefeuille.
Kan niet anders dan dat we €25+ gaan openen. 300 mio kasstroom....
Een omzet in het 4de kwartaal van maar liefst 941,5 miljoen met een cashflow van 304,5 naar een ongekende jaar omzet van 3.252,5 miljoen en ongelooflijke cashflow van 620,4 miljoen !!!
Onderbouwer schreef op 25 februari 2019 20:37 :
Kan niet anders dan dat we €25+ gaan openen. 300 mio kasstroom....
Die cashflow is gewoon onwerkelijk wat een verbetering, koers op korte termijn ruim boven de € 25,- en dan een bod van € 40,- en hoger !!!
Hoppa heren, dit is niet voor de poes.
Onderbouwer schreef op 25 februari 2019 20:27 :
Ik werd hier uitgelachen met mn cashflow prognoses!!! En jahoor er nog overheen zelfs!
Volgend jaar gewoon minimaal 1 miljard vrije kasstroom!
Morgen dikke FREEZE
...
En Badeend heeft iex dan geen gelijk?
Ik was al blij met een cashflow van mee dan 300 miljoen voor heel 2018 en hun verdubbelen dat nog eens ruim in het afgelopen 4de kwartaal, gewoon ongekende resultaten waar een verdubbeling van de koers op termijn bij hoort !!!
denk dat mijn opties mij een leuke auto gaan opleveren! (ik wacht nog wel even met bestellen:p)
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)